CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

New CRISPR-based sickle cell treatment, explainedПодробнее

FDA Approves First Crispr Treatment for Sickle Cell DiseaseПодробнее

FDA considers 1st CRISPR gene editing treatment that may cure sickle cell diseaseПодробнее

FDA approves first gene therapy for sickle cell diseaseПодробнее

Behind Gene Editing’s Big Moment with Sickle-Cell Treatment | WSJПодробнее

Gene editing could be a game changer for patients with sickle cell diseaseПодробнее

CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TEDПодробнее

FDA approves gene-editing therapy for sickle cell diseaseПодробнее

Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’Подробнее

CRISPR 2.0, the Next GenerationПодробнее

FDA approves gene editing treatments that may cure sickle cellПодробнее

Fmr. FDA Commissioner Dr. Scott Gottlieb on FDA approval of CRISPR treatment, CVS' new drug modelПодробнее

Breakthrough Economy: Cell and Gene Therapy InnovationsПодробнее

Can CRISPR cure Sickle-cell Disease?Подробнее

CRISPR gene-editing treatment for sickle cell disease explainedПодробнее

Newly approved breakthrough gene therapy possible cure for sickle cell disease?Подробнее

FDA greenlights first gene-editing treatment, Casgevy, for sickle cell diseaseПодробнее

The Age of CRISPR: Engineering the Future of Genetic Medicine | Benjamin Oakes | TEDxBerkeleyПодробнее

FDA approves gene therapy sickle cell treatmentПодробнее